Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 26, 2026
TickeronGET DAILY SIGNALS
Universal Health Realty Income Trust (UHT) Q3 2026 Earnings Preview

Universal Health Realty Income Trust (UHT) Q3 2026 Earnings Preview

Key Takeaways

  • Universal Health Realty Income Trust (UHT), a healthcare-focused real estate investment trust (REIT), is expected to report third-quarter 2026 results after the market close on October 26, 2026.
  • Wall Street anticipates revenue of roughly $24.9 million to $25 million, broadly in line with the trust's recent quarterly run rate.
  • Investors will focus on funds from operations (FFO), a key profitability measure for REITs, which reached $0.90 per share in the second quarter of 2026.
  • The $0.75 quarterly dividend, which translates to a yield of about 8%, and its coverage ratio remain the central watch items heading into the report.
  • Tenant concentration with Universal Health Services and the pressure from higher interest rates are the primary risk factors to monitor.
  • For more detail on UHT's Major News, Today's Price Move, Price Targets, and Forecast, explore the dedicated pages for this ticker.
  • Looking for new trade ideas? Explore Trending AI Robots for AI-driven market signals.

The Business Behind UHT and Why the Report Matters

Universal Health Realty Income Trust owns and leases healthcare and human-service properties across roughly 20 U.S. states, with about two-thirds of its asset value concentrated in medical office buildings and the remainder in acute care and behavioral health hospitals, freestanding emergency departments, and childcare centers. Because the trust earns recurring revenue from long-term leases with contractual rent escalators, its quarterly results are closely watched as a barometer of the healthcare real estate market. The upcoming report matters to income-focused investors because the trust's elevated dividend yield and tenant concentration with Universal Health Services leave it sensitive to both operating stability and borrowing costs. I also checked this using Tickeron’s AI Screener to see how UHT stacks up against other healthcare REITs.

Earnings Expectations

Analysts expect Universal Health Realty Income Trust to report third-quarter 2026 revenue of approximately $24.9 million to $25 million, a figure consistent with the $24.99 million reported in the second quarter of 2026 and the roughly $24.5 million recorded in the first quarter. On the earnings front, investors will look beyond the headline figure to FFO per share, which stood at $0.90 in the second quarter, up about 6.1% year over year, according to earnings-related commentary. The trust's GAAP (Generally Accepted Accounting Principles) earnings per share have been more volatile, ranging from $0.31 to $0.43 across recent quarters, reflecting non-cash items common to REITs. Beyond the top and bottom lines, key metrics include occupancy and leasing trends in the medical office portfolio, rent escalations, and the dividend coverage ratio. From what I see in the data, these details will help clarify the sustainability of the payout.

Market Reaction and Investor Sentiment

Sentiment heading into the third-quarter report has been cautious. UHT shares have pulled back from their 52-week high, pressured by rising Treasury yields and elevated interest rates, which weigh on rate-sensitive REITs through higher borrowing costs and compressed valuations. Google Finance data indicates the stock has traded in a range of roughly $35 to $46 over the past year, with the share price sitting near the lower portion of that band. Analysts have pointed to a high payout ratio as a source of concern for dividend sustainability, while recent institutional selling has added to the cautious tone. Against this backdrop, the market is likely to react to any signal that FFO and cash flow remain sufficient to support the $0.75 quarterly distribution.

Forward Outlook and Key Factors to Monitor

Following the third-quarter report, investors should watch several factors that will shape the trust's trajectory. First is dividend coverage: with a payout ratio that has run well above 100% of GAAP earnings, the relationship between FFO and the quarterly distribution will be scrutinized for any sign of strain.

Second is tenant concentration. Universal Health Services serves as the trust's advisor, its largest tenant, and the guarantor of leases on several hospital properties, representing roughly 40% of revenue. Any commentary on that tenant relationship or on lease renewals will carry outsized weight.

Third is the interest-rate environment. As a capital-intensive REIT, the trust's cost of debt refinancing and its ability to fund future acquisitions depend on where borrowing costs settle. Rising Treasury yields have already pressured the sector, and any change in the rate outlook could influence both valuation and growth plans.

Finally, investors should monitor occupancy and leasing activity across the medical office portfolio, as well as any updates on properties under construction. These operating details will help clarify whether the trust can sustain modest growth in FFO while preserving its high-yield distribution in a more expensive financing climate. I’m watching this closely with the help of Tickeron’s AI Trend Prediction Engine for any shifts in the broader REIT landscape.

Using Tickeron’s AI Tools in My Research

In preparing for earnings like this one from UHT, I frequently rely on Tickeron’s AI Screener to quickly filter healthcare REITs by fundamentals, technical patterns, and AI signals. It helps me compare dividend coverage, occupancy trends, and sector peers without spending hours on manual searches, giving a clearer picture of where risks and opportunities may lie. This kind of tool has become a regular part of my workflow for staying on top of income-focused names.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: UHT

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


UHT in downward trend: price dove below 50-day moving average on November 19, 2026

UHT moved below its 50-day moving average on November 19, 2026 date and that indicates a change from an upward trend to a downward trend. In 18 of 28 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 64%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UHT as a result. In 45 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.

The Moving Average Convergence Divergence Histogram (MACD) for UHT turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 32 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UHT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for UHT crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.

Following a +0.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where UHT advanced for three days, in 173 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

UHT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 92 of 224 cases where UHT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 41%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. UHT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 63 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.777) is normal, around the industry mean (3.134). P/E Ratio (28.137) is within average values for comparable stocks, (30.791). Projected Growth (PEG Ratio) (2.840) is also within normal values, averaging (1.649). Dividend Yield (0.077) settles around the average of (0.050) among similar stocks. P/S Ratio (5.705) is also within normal values, averaging (6.013).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UHT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock worse than average.

Industry description

The industry includes companies that publish and market books and magazines/periodicals. John Wiley & Sons, Inc., Meredith Corporation and Scholastic Corporation are some of the biggest companies in this industry. Like many other industries, publishing companies have branched out into online/digital publications (while retaining their original print business), to capture the burgeoning market in electronic media. Business could be cyclical in certain cases, since weak consumer sentiment during an economic downturn might depress sales of some magazines and books.

Market Cap

The average market capitalization across the Publishing: Books/Magazines Industry is 17.39B. The market cap for tickers in the group ranges from 113.09K to 176.55B. WELL holds the highest valuation in this group at 176.55B. The lowest valued company is DIGI at 113.09K.

High and low price notable news

The average weekly price growth across all stocks in the Publishing: Books/Magazines Industry was -2%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was -6%. MPT experienced the highest price growth at 5%, while XRN experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the Publishing: Books/Magazines Industry was 112%. For the same stocks of the Industry, the average monthly volume growth was 100% and the average quarterly volume growth was 205%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 61
Price Growth Rating: 53
SMR Rating: 77
Profit Risk Rating: 58
Seasonality Score: -2 (-100 ... +100)
Real Time Patterns 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a real estate investment trust

Industry PublishingBooksMagazines

Industry
Real Estate Investment Trusts
Address
367 South Gulph Road
Phone
+1 610 265-0688
Employees
5
Web
https://www.uhrit.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.